The research findings of Dr. Hisaki Makimoto from Jichi Medical University, utilizing the CLIDAS-PCI database, have been accepted for publication in Stroke. Antiplatelet therapy, which is essential after coronary intervention, plays a critical role in preventing coronary thrombosis but also carries a risk of cerebral hemorrhage. Analyses based on real-world data provide valuable insights for optimizing treatment strategies.
Preventive Effects of Prasugrel on Cerebrovascular Events Following Percutaneous Coronary Intervention.
Stroke. 2025 in press.
Makimoto H, Sasabuchi Y, Kabutoya T, Kohro T, Yamana H, Oba Y, Imai Y, Kario K, Sato H, Kiyosue H, Mizuno Y, Nochioka K, Nakayama M, Iwai T, Miyamoto Y, Ishii M, Nakamura T, Tsujita K, Akashi N, Fujita H, Yasunaga H, Matoba T, Nagai R, on behalf of the CLIDAS Research Group.